TickerFactsScreenerDevelopers

Protalix BioTherapeutics, Inc. (PLX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$31.97M2010: -$29.97M2011: -$36.53M2012: -$12.17M2013: -$34.06M2014: -$28.56M2015: -$23.67M2016: -$33.16M2017: -$34.52M2018: -$19.31M2019: -$10.72M2020: $2.71M2021: -$20.46M2022: -$13.01M2023: $10.46M2024: $3.92M2025: -$5.50M-$5.50M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$5.50M-240.4%
2024$3.92M-62.6%
2023$10.46M+180.4%
2022-$13.01M+36.4%
2021-$20.46M-855.1%
2020$2.71M+125.3%
2019-$10.72M+44.5%
2018-$19.31M+44.1%
2017-$34.52M-4.1%
2016-$33.16M-40.1%
2015-$23.67M+17.1%
2014-$28.56M+16.2%
2013-$34.06M-179.8%
2012-$12.17M+66.7%
2011-$36.53M-21.9%
2010-$29.97M+6.3%
2009-$31.97M—